Xun Chen
Known title: DirectorCIK: 0001284885
Xun Chen's purchase track record
How the stock did after each of Xun Chen's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
7
of 7 since October 11, 2021
Stock higher 6 months later
14%
3 months: 14%
Median 6-month return
-26.9%
3 months: -14.9%
Beat the S&P 500
14%
median -14.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/21/2022 | AMAT | $2K | -7.2% | +9.3% | +1.5% |
| 3/8/2022 | AMAT | $9K | -6.6% | -26.9% | -6.3% |
| 2/14/2022 | AMAT | $8K | -16.1% | -16.4% | -2.4% |
| 1/14/2022 | AMAT | $9K | -31.1% | -43.2% | -17.2% |
| 12/15/2021 | AMAT | $8K | -14.9% | -36.3% | -19.5% |
| 11/15/2021 | AMAT | $9K | -15.5% | -29.1% | -14.4% |
| 10/11/2021 | AMAT | $8K | +17.5% | -8.5% | +1.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AMAT | ▲ Buy | Grant | 741 | $0 | 3/12/2026 | View on chart |
| AMAT | ▲ Buy | Grant | 187 | $0 | 12/31/2025 | View on chart |
| AMAT | ▲ Buy | Grant | 1,583 | $0 | 3/6/2025 | View on chart |
| AMAT | ▲ Buy | Grant | 238 | $0 | 12/31/2024 | View on chart |
| AMAT | ▲ Buy | Grant | 1,128 | $0 | 3/7/2024 | View on chart |
| AMAT | ▲ Buy | Grant | 175 | $0 | 12/31/2023 | View on chart |
| AMAT | ▲ Buy | Grant | 2,050 | $0 | 3/9/2023 | View on chart |
| AMAT | ▼ Sell | Open Market | 199 | $21K | 1/20/2023 | View on chart |
| AMAT | ▼ Sell | Open Market | 178 | $19K | 1/20/2023 | View on chart |
| AMAT | ▲ Buy | Grant | 221 | $0 | 12/31/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 20 | $2K | 6/21/2022 | View on chart |
| AMAT | ▲ Buy | Grant | 1,920 | $0 | 3/10/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 37 | $5K | 3/8/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 36 | $4K | 3/8/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 30 | $4K | 2/14/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 30 | $4K | 2/14/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 28 | $5K | 1/14/2022 | View on chart |
| AMAT | ▲ Buy | Open Market | 28 | $4K | 1/14/2022 | View on chart |
| AMAT | ▲ Buy | Grant | 110 | $0 | 12/31/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 27 | $4K | 12/15/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 28 | $4K | 12/15/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 27 | $4K | 11/15/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 28 | $4K | 11/15/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 29 | $4K | 10/14/2021 | View on chart |
| AMAT | ▲ Buy | Open Market | 29 | $4K | 10/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AMAT Opens $5B EPIC Center Amid 21% Share Decline
Applied Materials opened a $5B EPIC Center, a new R&D facility, amid a 21% decline in its shares over the last eight sessions. The drop aligns with broader weakness in chip‑equipment stocks, driven partly by AI‑spending concerns. The EPIC Center launch may signal a focus on future growth, but the shares are near the $418.92 support level and have recently broken out of the Bollinger Bands. The shares are also touching the 200‑day moving average.
AMAT Opens $5B EPIC Center Amid 21% Share Decline. Applied Materials opened a $5B EPIC Center, a new R&D facility, amid a 21% decline in its shares over the last eight sessions. The drop aligns with broader weakness in chip‑equipment stocks, driven partly by AI‑spending concerns. The EPIC Center launch may signal a focus on future growth, but the shares are near the $418.92 support level and have recently broken out of the Bollinger Bands. The shares are also touching the 200‑day moving average.